Internal + Extramural
Please visit our website to find the complete and updated list of cancer-focused extramural funding opportunities or subscribe to UFHCC Opportunity to receive the weekly email.
Internal Opportunities
UFHCC Pilot and Exploratory Study Program
The Effects of Cancer on Aging Trajectories and Outcomes | LOI Due: 10/11/2021
Information Workshop: 9/20/2021 at 3:00 p.m. | Zoom Link, Meeting ID: 979 1329 4381 , Full Application: 11/1/2021
The Effects of Cancer on Aging Trajectories and Outcomes
We are pleased to announce a new pilot and exploratory study (PES) program to promote the development of collaborative research initiatives among Cancer Center members at the intersection of aging and cancer.
Extramural Opportunities
- Non-Limited Opportunities
- Non-Peer Reviewed Agencies
- Cancer Research Institute
- Mike Slive Foundation
- Pancreatic Cancer Action Network
- Pfizer
- National Foundation for Cancer Research
Non-Limited Opportunities
National Cancer Institute (NCI)
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
PAR-21-322 | Application: 10/5/2021
The NCI Transition Career Development Award (K22 – Independent Clinical Trial Required)
PAR-21-111 | Application: 10/12/2021
The NCI Transition Career Development Award (K22 – Independent Clinical Trial Not Allowed)
PAR-21-128
Application: 10/12/2021
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required)
PAR-21-318
Application: 10/12/2021
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)
PAR-21-296
Application: 10/12/2021
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
PAR-21-295
Application: 10/12/2021
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) PAR-21-323
Application: 10/16/2021
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) PAR-20-292
Application: 10/20/2021
National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
RFA-CA-21-020
Application: 10/28/2021
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) PAR-21-285
Application: 11/1/2021
Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed)
RFA-CA-21-041
Application: 11/1/2021
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) PAR-21-190
Application:11/8/2021
Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed) RFA-CA-21-049
Application: 11/12/2021
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) RFA-CA-21-048 Application: 11/12/2021
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) PAR-21-331
Application: 11/12/2021
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) PAR-21-332
Application: 11/18/2021
Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed) RFA-CA-21-058
Application: 11/19/2021
Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) PAR-21-306
Application: 2/8/2022
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
PAR-21-330
Application: 2/11/2022
Department of Defense (DOD)
Melanoma Research Program
Discovery Award | Pre-Application: 10/20/2021
National Institutes of Health (NIH)
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
RFA-HL-22-010
Application: 10/14/2021
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) RFA-HG-21-041
Application: 2/22/2022
Research to Improve Native American Health (R21 Clinical Trials Optional) PAR-20-2014
Application: 5/17/2022
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) PAR-20-238 | Application: 5/17/2022
American Cancer Society
SPECIAL INITIATIVE: Health Equity Research in Cancer Control and Prevention Application: 10/15/2021
The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services
Application: 4/1/2022
Melanoma Research Alliance
Young Investigator Award Checklist Due: 11/3/2021
Pilot Award Application: 11/17/2021
Non-Peer Reviewed Agencies
Cancer Research Institute
Clinic & Laboratory Integration Program (CLIP) LOI Due: 11/1/2021
Technology Impact Award LOI Deadline: 11/15/2021
Mike Slive Foundation
Mike Slive Foundation for Prostate Cancer Research Application: 10/1/2021
Pancreatic Cancer Action Network
Career Development Award Application: 10/25/2021
Pfizer
Acute Lymphoblastic Leukemia Peer-to-Peer Education & Support Application: 10/11/2021
PARP-inhibitor Combination Treatments in Prostate Cancer Application: 10/13/2021
National Foundation for Cancer Research
Szent-Györgyi Prize for Progress in Cancer Research Application: 10/15/2021